Trial intelligence / Profile preview

Histamine H2 blockade as adjunctive therapy in insufficient treatment response in schizophrenia

2006-006636-22Phase 4Completed

Sponsor
Jesper Ekelund
Start
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of famotidine in schizophrenia, sponsored by Jesper Ekelund. Started Jan 2007; status: completed.

02

Drugs

famotidine
03

Conditions

schizophrenia

Beyond the preview

Go deeper on 2006-006636-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006636-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call